Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis	Active, not recruiting	Phase 2	2026-08-05		NCT05556746

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Brigham and Women's Hospital	378
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic	2
Harvard School of Public Health (HSPH)	46
National Institute of Allergy and Infectious Diseases (NIAID)	402
University of California, Los Angeles	355
University of Cape Town	47
University of Stellenbosch	31

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
GHESKIO	Port-au-Prince	Haiti	1
University of Cape Town	Cape Town	South Africa	10